TEVA FY 2007 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$34B

FY 2007 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9.4B+11.9% YoY

Gross Profit

$4.9B51.8% margin

Operating Income

$2.4B25.5% margin

Net Income

$2.0B20.7% margin

EPS (Diluted)

$2.38

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.3B

Stock-Based Comp.

$67M

Balance Sheet

Total Assets

$23.4B

Total Liabilities

$9.7B

Stockholders' Equity

$13.7B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.4B	$8.4B	+11.9%
Gross Profit	$4.9B	$4.3B	+14.5%
Operating Income	$2.4B	$801M	+199.0%
Net Income	$2.0B	$546M	+257.5%